Allspring Global Investments Holdings LLC Sells 938 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Allspring Global Investments Holdings LLC trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 9.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,537 shares of the company’s stock after selling 938 shares during the period. Allspring Global Investments Holdings LLC’s holdings in HCA Healthcare were worth $2,542,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Integrated Advisors Network LLC increased its stake in shares of HCA Healthcare by 0.6% during the third quarter. Integrated Advisors Network LLC now owns 5,132 shares of the company’s stock worth $2,086,000 after purchasing an additional 31 shares during the period. BayBridge Capital Group LLC increased its stake in shares of HCA Healthcare by 1.0% during the third quarter. BayBridge Capital Group LLC now owns 3,485 shares of the company’s stock worth $1,416,000 after purchasing an additional 35 shares during the period. First Horizon Advisors Inc. increased its stake in HCA Healthcare by 2.4% during the 3rd quarter. First Horizon Advisors Inc. now owns 1,532 shares of the company’s stock worth $623,000 after acquiring an additional 36 shares during the period. Mediolanum International Funds Ltd increased its stake in HCA Healthcare by 0.3% during the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock worth $3,153,000 after acquiring an additional 36 shares during the period. Finally, Hartford Funds Management Co LLC increased its stake in HCA Healthcare by 1.6% during the 3rd quarter. Hartford Funds Management Co LLC now owns 2,469 shares of the company’s stock worth $1,003,000 after acquiring an additional 39 shares during the period. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

HCA has been the topic of a number of recent research reports. Truist Financial lowered their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Morgan Stanley reduced their target price on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. Oppenheimer raised their target price on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Bank of America reduced their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Finally, Royal Bank of Canada reduced their price target on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $316.07 on Friday. The company has a market cap of $78.49 billion, a PE ratio of 14.39, a price-to-earnings-growth ratio of 1.10 and a beta of 1.64. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The business has a 50 day moving average price of $313.53 and a 200-day moving average price of $350.84. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the firm earned $5.90 earnings per share. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.91%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.02%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.